We are live on
!
Find out more
Corvus Pharmaceuticals
CRVS
CRVS
61 hedge funds and large institutions have $136M invested in Corvus Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 10 increasing their positions, 16 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
156% more call options, than puts
Call options by funds: $7.17M | Put options by funds: $2.8M
116% more capital invested
Capital invested by funds: $63.2M → $136M (+$73.2M)
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
92% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 12
22% more funds holding
Funds holding: 50 → 61 (+11)
4.64% more ownership
Funds ownership: 61.8% → 66.43% (+4.6%)
38% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 16
Holders
61
Holders Change
+11
Holders Change %
+22%
% of All Funds
1.07%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
23
Increased
10
Reduced
16
Closed
12
Calls
$7.17M
Puts
$2.8M
Net Calls
+$4.38M
Net Calls Change
+$4.53M
Top Buyers
| 1 |
TCM
Tang Capital Management
San Diego,
California
|
+$11.1M |
| 2 |
VA
VR Adviser
New York
|
+$10.1M |
| 3 |
PVI
Pura Vida Investments
New York
|
+$2.17M |
| 4 |
IC
Ikarian Capital
Dallas,
Texas
|
+$1.95M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$1.7M |
Top Sellers
| 1 |
BI
BVF Inc
San Francisco,
California
|
-$6.83M |
| 2 |
EC
EcoR1 Capital
San Francisco,
California
|
-$4.43M |
| 3 |
O
OrbiMed
New York
|
-$3.28M |
| 4 |
CA
CHI Advisors
New York
|
-$1.64M |
| 5 |
Two Sigma Advisers
New York
|
-$770K |
